INSIGHT 2 : a Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance

Bron
Future oncology - ISSN 1479-6694- () p.
Auteur(s)
    Egbert F. Smit, Christophe Dooms, Jo Raskin, Ernest Nadal, Lye M. Tho, Xiuning Le, Julien Mazieres, How S. Hin, Masahire Morise, Viola W. Zhu, Daniel Tan, Kristina H. Holmberg, Barbara Ellers-Lenz, Svenja Adrian, Sabine Brutlach, Karl M. Schumacher, Niki Karachaliou, Yi-Long Wu

YEARS algorithm for diagnosis of suspected pulmonary embolism in patients with cancer

Bron
JAMA : the journal of the American Medical Association - ISSN 0098-7484- (2026) p.
Auteur(s)
    Bram Akerboom, Emily S.L. Martens, Milou A.M. Stals, Rolf E. Brouwer, Michiel Coppens, Giorgio Costantino, Francis Couturaud, Yordi P.A. van Dooren, Rene van der Griend, Olivier Hugli, David Jimenez, Pieter W. Kamphuisen, Ouiam El Kharbouchi, Lucia J.M. Kroft, Jenneke Leentjens, Martje L. Maas, Thijs E. van Mens, Isabelle Mahe, Oene A. van Meer, Mattijs Out, Roberto Pola, Jo Raskin, Marc Righini, Reinier A. Sprenger, Fleur H.J. Kaptein, Rosa Talerico, Tobias Tritschler, Marije ten Wolde, Frederikus A. Klok, Menno V. Huisman

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer : the Hydra Study

Bron
Thrombosis research - ISSN 0049-3848-263 (2026) p.
Auteur(s)
    E.S.L. Martens, B. Akerboom, C. Baumgartner, R.E. Brouwer, C. Cavallaro, M. Coppens, G. Costantino, F. Couturaud, A. D'Errico, Y.P.A. van Dooren, F. Gianni, R. van der Griend, M.J.J.H. Grootenboers, O. Hugli, T. van der Hulle, Z. Jaderi, D. Jimenez, P.W. Kamphuisen, V.R. Lanting, J. Leentjens, M.l. Maas, I. Mahe, O.A. van Meer, T.E. van Mens, M. Out, R. Pola, D. Pulver, Jo Raskin, M. Righini, R.A. Sprenger, M.A.M. Stals, R. Talerico, T. Tritschler, M. ten Wolde, F.A. Klok, M.V. Huisman